Casey Lynch - Chief Executive Officer, Director at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
QNCX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Casey Lynch since 4/21/2024

Holdings reported by Casey Lynch for Quince Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 979K $920K $0.94 Nov 18, 2021 By the Zachary and Casey Lynch Living Trust dated February 24, 2009
Common Stock 110K $103K $0.94 Nov 18, 2021 Direct
Common Stock 91.9K $86.4K $0.94 Nov 18, 2021 By The Casey C. Lynch 2019 Annuity Trust
Stock Option (right to buy) 440K Jan 3, 2022 Direct Common Stock

Transactions reported by Casey Lynch for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.